HomeNewsBusinessMarketsChartist Talks | What makes Rohit Srivastava of Indiacharts bullish on pharma stocks for FY25?

Chartist Talks | What makes Rohit Srivastava of Indiacharts bullish on pharma stocks for FY25?

The healthcare stocks offer a valuation advantage which will keep a safety net in place, says Indiacharts' Rohit Srivastava.

March 04, 2024 / 07:01 IST
Story continues below Advertisement
Indiacharts' founder Rohit Srivastava
Rohit Srivastava is the Founder of Strike Money Analytics and Indiacharts

After the Nifty 50 hit a new record high last week, the trendline indicated a new resistance near 22,360. The index needs to trade above this level for a few days to prove that the breakout from consolidation was sustainable, according to Rohit Srivastava, founder of Strike Money Analytics and Indiacharts.

The veteran with nearly three decades spent in the equity markets shared with Moneycontrol in an interview that pharma or healthcare was the only sector that has the hope to stand out in FY25.

Story continues below Advertisement

Srivastava appears bullish about the market trends but stays cautious. Excerpts from the interview:

Do you expect the rally to be unstoppable with the Nifty 50 past 23,000?